USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
      Featured
      Our Next Event
      Register for LSI USA ‘26
      500+ Investors & Strategics
      See LSI USA '26 Attendee List
      Events Overview
      • Our Summits
      • Who Attends
      • Why Present
      Upcoming Summits
      • LSI USA ‘26
      • LSI Asia ‘26
      • LSI Europe '26
      Past Summits
      • LSI USA ‘25
      • LSI Asia ‘25
      • LSI Europe ‘25
      • Archives
  • Insights
      Featured
      Just Launched
      Compass AI
      New Report
      Emerging Innovators Report
      Compass Al
      Emerging Innovators Report
      Market Data
      Custom Research
  • Magazine
      Featured
      February Edition
      Explore Latest Editions
      The Lens Magazine
      Start Your Subscription
      Magazine
      • The Lens Magazine
      • Explore the Newest Edition
      • Read Free Articles
  • Resources
      Featured
      Released Weekly
      The LSI Alumni Weekly Recap
      Just Released
      2025 LSI Alumni Funding Report
      Resources
      • Research Desk
      • Testimonials
      • Video Library
      • Photo Gallery
  • Company
      Featured
      Our Next Event
      Register for LSI USA '26
      Just Launched
      Compass AI
      Company
      • About Us
      • Our Team
      • Press
  • Contact Us
Contact Us
USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
  • Insights
  • Magazine
  • Resources
  • Company
Events Overview
  • Our Summits
  • Who Attends
  • Why Present
Upcoming Summits
  • LSI USA ‘26
  • LSI Asia ‘26
  • LSI Europe ‘26
Past Summits
  • LSI USA ‘25
  • LSI Asia ‘25
  • LSI Europe ‘25
  • Archives
Featured
Our Next Event
Register for LSI USA '26
350+ Investors & Strategics
See LSI USA '26 Attendee List
Compass Al
Emerging Innovators Report
Market Data
Custom Research
Featured
Just Launched
Compass AI
New Report
Emerging Innovators Report
Magazine
The Lens Magazine
Explore the Newest Edition
Read Free Articles
Featured
February Edition
Explore Latest Editions
The Lens Magazine
Start Your Subscription
Resources
Research Desk
Testimonials
Video Library
Photo Gallery
Featured
Released Weekly
The LSI Alumni Weekly Recap
Just Released
2025 LSI Alumni Funding Report
Company
About Us
Our Team
Press
Featured
Our Next Event
Register for LSI USA '26
Just Launched
Compass AI
Join our Next Event
LSI USA ‘26, March 16-20, 2026
Waldorf Astoria, Monarch Beach
Register Today
Compass AI
The medtech-specific AI
research platform by LSI
Demo Compass AI
The Lens Magazine
The Lens Medtech
Magazine is LSI's most
curated industry coverage.
  1. Video Library
  2. Building a Winning Board — Hits and Misses | LSI USA '25

Building a Winning Board — Hits and Misses | LSI USA '25

Moderator Nick Pachuda leads an insightful discussion with industry experts Tamir Meiri (JJDC - Johnson & Johnson), Jeff O'Donnell Sr., Rui Jing Jiang (Avisi Technologies), and Stefan Fischer on key strategies, successes, and common pitfalls in building effective medtech boards.
Share social-facebook social-x social-linkedin
View Video Transcript
lsi logo
Contact Us

Upcoming Events

LSI USA ‘26
LSI USA ‘26
March 16-20, 2026
Dana Point, CA
LSI ASIA ‘26
LSI ASIA ‘26
June 30 - July 2, 2026
Singapore
LSI EUROPE ‘26
LSI EUROPE ‘26
Sept 28 - Oct 1, 2026
Barcelona

More From LSI

  • Attend an Event
  • Sponsor an Event
  • Compass, by LSI
  • The Lens, Magazine by LSI

Resources

  • Research Desk
  • Photo Gallery
  • Video Library
  • Testimonials
  • About Us

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540

© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy

Request Info
close
STEP 1
close-icon
The Lens - Complimentary Issue
close
close

Subscription Includes

Request Info

Global Medtech Market Analysis & Projections (MAP), 2021-2031
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf report

The Global Medtech Market Analysis and Projections (MAP) provides global market forecasts (2021 – ’31), share-by-supplier data, and analyst insights on 23 major device markets (e.g., Cardiovascular, Orthopedics, Neurovascular, In-Vitro Diagnostics) and 200+ technology subsegments. Understand major market trends and projections across the medtech industry with what medtech strategics and consulting firms have referred to as their “gold standard” for device market sizing data.

Global Surgical Procedure Volumes Dashboard, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Global Surgical Procedure Volumes database is the single source of truth for understanding diagnostic and therapeutic procedure volumes on a global scale. With coverage on 37 countries, including the United States, Europe’s Big Five, China, India, Japan and more for 12 major procedure markets (Cardio, Ortho, General Surgery, Radiosurgery, Neuro, OB/GYN and more), this fully interactive database is designed to facilitate one-to-one analyses of procedures, countries, and regions. Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

United States Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United States Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United States. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Aesthetics, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Aesthetics Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Aesthetics Procedures Database covers major aesthetic procedures, including: Biopsies, Punch Biopsies, Shave Biopsies, Incisional Biopsies, Lesion Removal Procedures, Curettage, electrocautery, and electrocoagulation lesion destruction, Photodestruction, Cryotherapy-based lesion destruction, Lesion Removal Procedures: Traditional and Other, Abdominoplasty, Blepharoplasty, Breast Augmentation, Breast Lift, Breast Reduction, Buttock Augmentation, Buttock Lift, Cheek Implants, Chin Augmentation, Facelift, Forehead Lift, Gynecomastia Treatment, Hair Transplantation, Lip Augmentation, Liposuction, Lower Body Lift, Otoplasty, Rhinoplasty, Thigh Lift, Upper Arm Lift, Vaginal Rejuvenation, Surgeries for Cleft Palate and Lip, Surgeries for Burn Injuries.

Cardio, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Cardiothoracic and Interventional Cardiology Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Cardiothoracic and Interventional Cardiology Procedures Database covers major cardiothoracic and interventional cardiology procedures, including: CABG Surgeries Off-Pump CABG, On-Pump CABG, Valve Procedures Aortic Valve Replacements, Mitral Valve Replacements, MV Repairs, AV Repairs, PV Replacements, PV Repairs, TV Operations, Percutaneous Valvuloplasties, Percutaneous Valve Replacements, CHD Surgeries Ventricular Septal Defect Closures, Patent Ductus Arteriosus Repairs, Atrial Septal Defect Closures, Repair of Tetralogy of Fallot, Arterial Shunts Surgeries, Atrioventricular Septal Defect Repairs, Transposition of Great Artery Procedures, Anomalous Pulmonary Venous Return Repairs, Other Congenital Heart Disease Surgeries, Other Cardiothoracic Surgeries Aortic Aneurysm Procedures, Other Cardiothoracic Surgeries, Diagnostic and Therapeutic Catheterizations, Stand-Alone Diagnostic Cardiac Catheterizations, Percutaneous Coronary Interventions, Coronary Interventions Radial Approach, Coronary Interventions Femoral Approach, Heart Rhythm Procedures Conventional Pacemaker Procedures, ICD Procedures, Cardiac Resynchronization Device Procedures, Combined Defib/Resynch Device Procedures, Cardiac Ablations.

ENT, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ear, Nose, and Throat Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ear, Nose, and Throat Surgical Procedures Database covers major ear, nose, and throat procedures, including: Tonsillectomies, Operations on the Ear, FESS, Tracheostomies, Thyroidectomies & Parathyroidectomies, Stand-Alone Adenoidectomies, Tongue Operations, Laryngeal Operations, Pharyngeal Operations, Radical Neck Dissection.

General, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The General Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The General Surgeries Procedures Database covers major general surgical procedures, including: Cholecystectomies Laparoscopic Cholecystectomies, Open Cholecystectomies, Appendectomies, Laparoscopic Appendectomies, Open Appendectomies, Herniorrhaphies Laparoscopic Herniorrhaphies, Open Herniorrhaphies, Bariatric Surgeries Laparoscopic Bariatric, Open Bariatric, Selected Other Endoscopic General & Colorectal Procedures Esophageal (Other Endoscopic), Stomach & Intestinal (Other Endoscopic), Colorectal (Other Endoscopic), Liver (Other Endoscopic), Gallbladder & Biliary (Other Endoscopic), Pancreatic (Other Endoscopic), Other (Other Endoscopic), Other Surgeries Esophageal (Other General, non-Endoscopic), Stomach & Intestinal (Other General, non-Endoscopic), Colorectal (Other General, non-Endoscopic), Liver (Other General, non-Endoscopic), Gallbladder & Biliary (Other General, non-Endoscopic), Pancreatic (Other General, non-Endoscopic), Other (Other General, non-Endoscopic).

Neuro, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Neurosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Neurosurgery Procedures Database covers major neurosurgical procedures, including: Surgeries for Traumatic Brain Injuries, Ventricular & Shunt Surgeries, New Shunt Placements, Revision Shunt Surgeries, Endoscopic Third Ventriculostomies, Diagnostic Ventricular Endoscopies, Vascular Lesion Procedures, Vascular Lesion Surgeries, Vascular Lesion Coil Procedures, Pituitary Tumor Surgeries, Open Pituitary Tumor Surgeries, Endoscopic Pituitary Tumor Surgeries, Intracranial Tumor Surgeries, Open Intracranial Tumor Surgeries, Endoscopic Intracranial Tumor Surgeries, Cranioplasties, Intracranial Neurostimulation and Peripheral Nerve Procedures, Intracranial Neurostimulator Implant Procedures, Peripheral Nerve Neurostimulation Procedures, Other Peripheral Nerve Procedures.

OB/GYN, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Obstetric and Gynecological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Obstetric and Gynecological Surgical Procedures Database covers major obstetric and gynecological procedures, including: Obstetrical Surgeries Cesarean Sections, Destructive Operations, Episiotomies, Other Obstetrical Surgeries, Gynecological Surgeries Colposcopies, Hysterectomies, Salpingo-Oophorectomies & Oophorectomies, Colposcopies, Salpingo-Oophorectomies & Oophorectomies, Hysterectomies, Total Hysterectomies, Subtotal Hysterectomies, Vaginal Hysterectomies, Breast Cancer Surgeries, Breast Reconstruction Surgeries, Breast-Conserving Surgeries, and Mastectomies, among other surgeries.

Ophthalmology, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ophthalmological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ophthalmological Surgical Procedures Database covers major ophthalmological procedures, including: Cataract Surgeries, Phacoemulsification Surgeries, ICCE Surgeries, ECCE Surgeries, MSICS Surgeries, Refractive Surgeries.

Orthopedic, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Orthopedic Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Orthopedic Surgical Procedures Database covers major orthopedic procedures, including: Hip Arthroplasties Revision Hip Arthroplasties, Hip Resurfacing Procedures, Primary Hip Arthroplasties - Total Hip, Partial Hip, Knee Arthroplasties Revision Knee Arthroplasties, Primary Knee Arthroplasties - Partial Knee, Primary Knee Arthroplasties - Total Knee, Extremity Fractures Using Hardware Extremity Fractures Using Hardware - Upper Extremities, Extremity Fractures Using Hardware - Fractures of the Femoral Neck & Shaft, Extremity Fractures Using Hardware - Other Lower Extremity, Arthroscopies Knees (Arthroscopies), Shoulders (Arthroscopies), Ankles (Arthroscopies), Feet & Toes (Arthroscopies), Others (Arthroscopies), Other Joint Arthroplasties Finger & Hand, Wrist, Elbow, Shoulder, Ankle & Foot.

Peripheral Vascular, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Peripheral Vascular Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Peripheral Vascular Surgeries Procedures Database covers major peripheral vascular procedures, including: Arterial Procedures Thrombectomies & Thromboendarterectomies, Carotid Artery Thrombectomies, Upper Limb Artery Thrombectomies, Iliac Artery Thrombectomies, Renal Artery Thrombectomies, Lower Limb Artery Thrombectomies, Arterial Angioplasties, Carotid Artery Angioplasties, Upper Limb Artery Angioplasties, Iliac Artery Angioplasties, Renal Artery Angioplasties, Lower Limb Artery Angioplasties, Arterial Bypasses, Carotid Artery Bypasses, Upper Limb Artery Bypasses, Iliac Artery Bypasses, Renal Artery Bypasses, Aortofemoral and Aortobifemoral Bypasses, Femoropopliteal Bypasses, Femorotibeal Bypasses, Other Lower Limb Bypasses, Venous Procedures Head, Neck, & Upper Limb Thrombectomies & Thromboendarterectomies of Dialysis Access Venous Segments, Thrombectomies & Thromboendarectomies of Other Upper Limb Veins, Angioplasties of Dialysis Access Venous Segments, Angioplasties of Head, Neck and Other Upper Limb Veins, Lower Limb Venous Procedures Removals of the Saphenous Vein, Removals of Other Veins of the Lower Limbs.

Spine, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spine Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Spine Surgical Procedures Database covers major spine procedures, including: Cervical Spine Surgeries Cervical Spine Decompressions, Cervical Spine Discectomies, Cervical Spine Fusions, Cervical Spine Disc Replacements, Thoracic and Deformity Procedures Thoracic Spine Decompressions, Thoracic Spine Discectomies, Thoracic Spine Fusions, Instrumented Procedures for Deformities, Lumbar Procedures Lumbar Spine Decompressions, Lumbar Spine Discectomies, Lumbar Spine Fusions, Insertion of Lumbar Interspinous Process Spacer, Lumbar Spine Disc Replacements, Vertebroplasties & Kyphoplasties Vertebroplasties, Kyphoplasties, Other Spine Surgeries.

SRS, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Stereotactic Radiosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Stereotactic Radiosurgery Procedures Database covers major stereotactic radiosurgery procedures, including: Intracranial SRS Procedures, Extracranial SRS Procedures, Extracranial Spine Procedures, Extracranial Lung Procedures, Other Extracranial Procedures.

Urological, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Urological Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Urological Surgeries Procedures Database covers major urological procedures, including: Kidney Stone Procedures Extra Corporeal Shock Wave Lithotripsy, Percutaneous Nephro Lithotripsy, Ureteroscopies, Open Kidney Stone Procedures, BPH Procedures Transurethral Prostatectomies, Other BPH Surgeries, Prostatectomies, Nephrectomies Partial Nephrectomies, Radical Nephrectomies, Bladder Procedures Therapeutic Endoscopies, Diagnostic Endoscopies, Urethral Catheterizations of Bladder.

Global Markets for Hip Replacement Implants, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for hip replacement implants. The market for hip replacement implants includes all prosthetic devices used to replace damaged sections of the hip joint, including those used in total and semi/hemi replacement procedures. This market snapshot is intended to provide a high-level overview of the global market for hip replacement implants, with key insights into: Procedure volumes from 2022 to 2028, Market forecasts from 2022 to 2028, Competitive landscape analysis of major competitors, Insights into key market events for strategics and startups. Companies covered in this report include: B. Braun, DePuy Synthes, DJO Global, Exactech, Johnson & Johnson, Medacta, MicroPort Scientific, Ortho Development, OSSIS, SERF SAS, Smith+Nephew, Symbios Orthopedie, Total Joint Orthopedics, Zimmer Biomet.

Global Markets for Peripheral Vascular Guidewires, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Atherectomy Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Electrosurgery, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Vascular Balloons & Vena Cava Filter, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for percutaneous transluminal angioplasty (PTA) balloons and inferior vena cava (IVC) filters. A PTA balloon is used in the treatment of peripheral artery disease (PAD) to open a narrowed or blocked artery. IVC filters are permanent or temporary devices to prevent the travel of thrombotic material to the lungs. These devices are frequently used in the management of patients with severe PAD. This market snapshot is intended to provide a high-level overview of the global market for PTA balloons and IVC filters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Acotec Scientific, Adient Medical, B. Braun, BD, Biotronik, Boston Scientific, Brosmed, Cagent Vascular, Cardinal Health, CONMED, Cook Medical, Concept Medical, Cordis, Covellus, Degania Medical, iVascular, Medtronic, Merit Medical, NextStep Medical, Nipro, OrbusNeich, Orchestra BioMed, Philips, Terumo, TriReme Medical.

Global Markets for Mechanical Heart Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Tissue Heart Valve Replacement, 2023-2028
Published:
2023
Next Update:
Q2 2030
Deliverables:
excel pdf

Description coming soon.

Global Markets for Transcatheter Mitral Valve Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Femoral Closure, 2023-2029
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for femoral closure devices. Femoral closure devices are used to achieve hemostasis of the hole in the artery that is created to perform catheter-based cardiovascular or endovascular procedures. This market snapshot is intended to provide a high-level overview of the global market for femoral closure devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Cardinal Health, Cardiva, Cordis, CyndRx, Endocor, Haemonetics, Morris Innovative, Rex Medical, Teleflex, Terumo, Transluminal Technologies, Vasorum, Vivasure Medical.

Global Markets for Tricuspid Valve Repair, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for tricuspid valve repair devices. Tricuspid valve repair is the preferred surgical approach for the treatment of degenerative tricuspid valve disease. The market is currently experiencing a renaissance with the introduction and development of transcatheter solutions for tricuspid valve repair and replacement. Devices covered within the scope of this analysis include tricuspid valve annuloplasty rings and transcatheter tricuspid valve repair devices. This market snapshot is intended to provide a high-level overview of the global market for tricuspid valve repair devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, CroiValve, Edwards Lifesciences, Innoventric, Medtronic, Mitral Holdco, Mitralix, NaviGate, OrbusNeich, TriCares, Venus Medtech.

Global Markets for Percutaneous Pulmonary Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for transcatheter pulmonary valve devices. Pulmonary valve replacement is performed primarily for the treatment of pulmonary valve stenosis, a relatively rare disease associated with congenital heart defects. Devices covered within the scope of this analysis include transcatheter pulmonary valve implants for valve repair and replacement. This market snapshot is intended to provide a high-level overview of the global market for transcatheter pulmonary valve devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Edwards Lifesciences, Medtronic, PolyVascular, Venus Medtech.

Global Markets for Coronary Angio Guidewires & Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for coronary angiography catheters and guidewires. These devices are essential to perform coronary angiography, a minimally invasive medical procedure used to visualize blood flow, identify blockages and narrowing of the coronary arteries. Devices covered within the scope of this analysis include coronary angiography catheters and coronary angiography guidewires. This market snapshot is intended to provide a high-level overview of the global market for coronary angiography catheters and guidewires, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AngioDynamics, B. Braun, Boston Scientific, Cardinal Health, Cook Medical, Cordis, Medtronic, Merit Medical, Philips, Teleflex, Terumo.

Global Markets for Oncology Ablation Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology ablation catheters. These devices are used as a therapeutic modality employing energy to selectively destroy cancerous tissue. Devices covered within the scope of this analysis include radiofrequency and microwave ablation electrodes, excluding cryoablation devices, which are covered in a separate report. The snapshot offers a high-level overview of the global market for oncology ablation catheters and guidewires, with key insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: AngioDynamics, Baylis, Boston Scientific, Canyon Medical, CAPS Medical, EDAP, Galvanize Therapeutics, Imagin Medical, Medtronic, Mermaid, Mirai Medical, Monteris, Sonablate, Stryker, TROD Medical, and US Medical Innovations.

Global Markets for ENT Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for endoscopic devices for ear, nose, and throat (ENT) surgery. These devices are used to examine and operate on the structures and tissues in the ear, nose, and throat. Devices covered within the scope of this analysis include ENT endoscopic surgical instruments, balloon sinus and dilation catheters, and rigid endoscopes and bronchoscopes. This market snapshot is intended to provide a high-level overview of the global market for ENT endoscopic surgery devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: 3NT Medical, Acclarent, Conmed, Endoluxe, Entellus Medical, Intuitive Surgical, Johnson & Johnson, KARL STORZ, Medtronic, Olympus, Pentax, Pristine Surgical, Richard Wolf, Smith & Nephew, Stryker, Tympany Medical.

Global Markets for Cell Delivery Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cell delivery catheters. These devices are primarily research-use devices for the delivery of cellular therapies for the treatment of chronic diseases, such as cardiovascular disease and cancer. Devices covered within the scope of this analysis include cell delivery catheters. This market snapshot is intended to provide a high-level overview of the global market for cell delivery catheters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: BioCardia, Biosense Webster, Boston Scientific, Cordis, Medtronic, Mercator MedSystems, TriSalus Life Sciences, TRI Medical.

Global Markets for Urology Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for urology and renal devices, focusing on treatments for six major conditions: End-stage renal disease (ESRD), Incontinence, Calculi (stones), Benign prostatic hyperplasia (BPH), Prostatitis, and Erectile dysfunction (ED). The devices covered within this analysis encompass a range of tools for diagnosis, treatment, and management, including urinary bags, foley catheters, catheter insertion kits, intermittent catheters, endourology devices, BPH ablation devices, lithotripsy devices, and artificial penis devices. The snapshot provides key insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: 3M, Applied Medical, Astratech, Balton, Baxter Healthcare, B. Braun, BD, Boston Scientific, Calyxo, Corinth Medtech, Coloplast, EndoMed, Flume Catheter Company, Hollister, ICU Medical, Karl Storz, Medline, Medtronic, Merit Medical, Nipro, Olympus, SonoMotion, Teleflex, and Urovision.

Global Markets for External Pain Pumps, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for external pain pumps. These devices are used to provide patients with consistent, long-lasting pain relief by delivering pain medication epidurally, intravenously, or subcutaneously. Devices covered within the scope of this analysis include external infusion pumps for pain management. This market snapshot is intended to provide a high-level overview of the global market for external pain pumps, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Avanos, B. Braun, BioQ Pharma, Epic Health, ICU Medical, InfuTronix, Medical Flow Systems, Medipacs, MicroPort, Smiths Medical, Teleflex.

Global Markets for Ureteral Access Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence delves into the global market for ureteral access devices, crucial components utilized alongside ureteroscopy or percutaneous nephrolithotomy procedures. These devices facilitate dilation and create a working channel for various urologic interventions. The snapshot aims to offer insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it provides a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Amecath, Applied Medical, BD, Boston Scientific, Cook Medical, Envaste, Johnson & Johnson, Mednova, Olympus, Richard Wolf, Rocamed, Teleflex, and Terumo.

Global Markets for Pelvic Floor Repair, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for pelvic floor repair mesh. These products are used during surgical procedures to repair prolapse and urinary incontinence. Devices covered within the scope of this analysis include pelvic floor repair/reconstruction mesh. This market snapshot is intended to provide a high-level overview of the global market for pelvic floor repair mesh, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: BD, Boston Scientific, Coloplast, Cook Medical, Ethicon, Johnson & Johnson.

Global Markets for Atrial Fibrillation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Neurovascular Devices Ischemic, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence analyzes the global market for devices used in the treatment of ischemic stroke, focusing on solutions designed to remove occlusions in blood vessels to prevent and treat this condition. The market snapshot offers insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Cerenovus, Ceretrieve, Cordis, InNeuroCo, Julier, Medtronic, MicroPort Scientific, Microvention, Penumbra, Phenox, Poseydon Medical, Route 92 Medical, Stryker, and Terumo.

Global Markets for Neuromodulation Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global neuromodulation market – a thriving market for managing and treating neurological diseases, chronic pain, and other chronic conditions. Types of neuromodulation, or neurostimulation, devices include implantable and transcutaneous devices, including wearable devices. This market snapshot is intended to provide a high-level overview of the global neuromodulation market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bionics, Alyve Medical, Axonics, Biotronik, Boston Scientific, EBT Medical, electroCore Medical, Inspire Medical, LivaNova, Medtronic, Neuromod Devices, Nevro.

Global Markets for Vertebroplasty Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vertebral augmentation products, which are crucial in treating vertebral compression fractures, often caused by osteoporosis or spinal tumors. Vertebroplasty and kyphoplasty are the primary surgical interventions, and the market includes products such as vertebroplasty and kyphoplasty cement, as well as delivery devices. The snapshot aims to provide a comprehensive overview of the global vertebral augmentation products market, with key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Halma, IZI Medical, Medtronic, Mendec, Merit Medical, RevBio, and Stryker.

Global Markets for TAVI/TAVR, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Drug Delivery, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Benign Prostation Hyperplasia Implants, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement. This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Butterly Medical, Endotherapeutics, Olympus, ProArc, ProVerum, Teleflex, Urotronic, ZenFlow.

Global Markets for Cryoablation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for cryoablation devices for non-cardiovascular applications. These devices are used to freeze and induce cellular damage and death for indications including cancer, dermatological conditions, peripheral vascular disease, and urological conditions. This market snapshot is intended to provide a high-level overview of the global cryoablation devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Boston Scientific, Brymill Cryogenics, Channel Medsystems, CooperSurgical, CPSI Biotech, CryoConcepts, CryoProbe, CryoSurgery, CSA Medical, Endocare, Endocision, Grand Cryo, Ictero Medical, KryoLife, Mectronic Medical, Sedivention, Siemens Healthineers, Varian Medical Systems, Wallach Surgical.

Global Markets for Diagnostic Electrophysiology Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for diagnostic electrophysiology catheters. These devices are used to measure and map electrical activity within the heart to identify aberrant electrical activity that causes arrhythmias. LSI projects that this market will remain in a high growth phase due to improving technology for the surgical treatment of cardiac arrhythmias and atrial fibrillation (AF). This market snapshot is intended to provide a high-level overview of the global diagnostic electrophysiology catheters market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AccuPulse, Acutus Medical, BD, Biosense Webster, Boston Scientific, CardioNXT, CoreMap, Johnson & Johnson, Kardium, Medtronic, MicroPort Scientific, Stereotaxis.

Global Markets for Hernia Repair, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence (LSI) provides an analysis of the global market for hernia mesh products for the surgical repair of hernias. The global market for hernia mesh products is projected to see moderate growth throughout the forecast period covered by the analysis. While the market has been negatively impacted by ongoing lawsuits associated with product complications, the next generation of products has helped the market to recover for one of the most performed abdominal surgeries. This market snapshot is intended to provide a high-level overview of the global market for hernia mesh products, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Allergan, Ariste Medical, BD, Cook Medical, Deep Blue Medical Advances, Ethicon, Exogenesis, Integra Lifesciences, Johnson & Johnson, LifeCell, Medtronic, Novus Scientific, Tarian Medical, TELA Bio, TISSIUM, W.L. Gore.

Global Markets for CRM Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore the natural rhythm and function of the heart that can be impaired as a result of cardiac rhythm disorders and heart failure. This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AtaCor Medical, BioTrace Medical, Biotronik, Boston Scientific, Cairdac, Electroducer, FineHeart, Lepu Medical, LivaNova, Medico, Medtronic, Merit Medical, Microport Scientific, Osypka Medical, Pacetronix.

Global Markets for Neurovascular Devices Hemorrhagic, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for neurovascular devices for the treatment of hemorrhagic stroke. These solutions are used to treat intracerebral bleeds, ruptured aneurysms, and other neurovascular deformities that lead to the pooling of blood vessels that have ruptured inside and outside of the brain. This market snapshot is intended to provide a high-level overview of the global market for neurovascular devices for hemorrhagic stroke, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Acandis, Artio Medical, Endostream Medical, Medtronic, MicroPort Scientific, Microvention, Phenox, Penumbra, Rapid Medical, Shape Memory Medical, Stryker, Terumo, Wallaby Medical.

Global Markets for Renal Denervation, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for renal denervation devices for the treatment of refractory hypertension (i.e., high blood pressure that does not respond to pharmaceuticals). The market for renal denervation devices includes radiofrequency and ultrasound catheters which are used to ablate the renal nerves. This market snapshot is intended to provide a high-level overview of the global market for renal denervation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Ablative Solutions, Brattea, Medtronic, Metavention, Otsuka Medical, ReCor Medical, SoniVie.

Global Markets for Upper+Lower Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence analyzes the global market for suture anchors used in upper and lower extremity repair and reconstruction procedures. Suture anchors play a critical role in securing soft tissue to bone, particularly for severe soft tissue tears. The market encompasses bioabsorbable, biocomposite, metallic, and PEEK suture anchors. The snapshot aims to offer insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Acumed, Acuitive Technologies, aevumed, Anika Therapeutics, Arthrex, ConMed, DePuy Synthes, Johnson & Johnson, Mitek, OSSIO, Paragon 28, Responsive Arthroscopy, Riverpoint Medical, Smith & Nephew, Stryker, and Zimmer Biomet.

Global Markets for Peripheral Stents, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for biliary and peripheral vascular stents. These devices are used to maintain and restore patency to anatomical ducts or vessels that have become obstructed due to the formation of plaque, narrowing of the natural lumen, or presence of benign and malignant growths. This market snapshot is intended to provide a high-level overview of the global peripheral vascular and biliary stents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, BD, Biotronik, Boston Scientific, Bryan Medical, Cardinal Health, Cook Medical, Cordis, Endo GI Medical, Hood Labs, Maquet, Medtronic, Merit Medical, MicroPort Scientific, Olympus, Q3 Medical, Zorion Medical.

Global Markets for Electromagnetic Navigation Systems, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for electromagnetic navigation systems for tracking, guiding, and positioning instruments during surgery. These systems provide surgeons and the surgical team with real-time information on the position and orientation of instruments used during open and minimally invasive surgeries. This market snapshot is intended to provide a high-level overview of the global electromagnetic navigation systems market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Brainlab, Collin Medical, Elucent Medical, Fiagon, Heal Force, Joimax, Karl Storz, Medtronic, Olympus, Stryker, Veran Medical Technologies.

Global Markets for GI Endoscopy, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot report from Life Science Intelligence provides an analysis of the global market for gastrointestinal (GI) endoscopic devices. These devices are used to visualize, diagnose, and surgically treat conditions of the GI tract. The market for GI endoscopic devices includes endoscopes and endoscopic instruments. This market snapshot is intended to provide a high-level overview of the global market for GI endoscopic devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Ambu, Applied Medical, Aqua Medical, Aspero Medical, B. Braun, Boston Scientific, ConMed, Endoluxe, Ethicon, Integra Lifesciences, Intuitive Surgical, IQ Endoscopes, Johnson & Johnson, Karl Storz, Medtronic, MiWendo Solutions, Olympus, Purple Surgical, Richard Wolf, Stryker, Teleflex.

Global Markets for Hemodialysis, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for hemodialysis solutions. Hemodialysis is an essential treatment for patients suffering from end-stage renal disease due to kidney failure. Hemodialysis systems, catheters, and dialyzers are components integral to hemodialysis treatment. This market snapshot is intended to provide a high-level overview of the global hemodialysis solutions market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Asahei Kasei, AngioDynamics, B. Braun, Baxter, Bellco, Byonyks, Diality, Fresenius, Hemoclean, Humacyte, Intermedt, Inspira Health, iRen-MEDICAL, Medivators, Merit Medical, NextKidney, Nikkiso, Nipro, Rockwell Medical, Telelfex, Terumo, Toray Medical, TVA Medical, Vantive.

Globals Markets for Cardiac Ablation, 2023-2028
Published:
Next Update:
Deliverables:

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac ablation devices, which are used for the treatment of arrhythmic heart conditions, such as atrial fibrillation. The market for cardiac ablations devices is projected to see strong growth throughout the forecast period covered by this analysis, driven by demographic trends and the adoption of new technologies for the treatment of new ablation technologies, such as Pulsed Field Ablation. Devices covered within the scope of this analysis include cardiac ablation catheters. This market snapshot is intended to provide a high-level overview of the global market for cardiac ablation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Adagio Medical, AtriAN Medical, AtriCure, Biosense Webster, Boston Scientific, Electrophysiology Frontiers, Field Medical, Galvanize Therapeutics, Healium Medical, Johnson & Johnson, Medtronic, Stereotaxis.

Global Markets for Atrial Septal Occlusion, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for atrial septal occlusion devices. These devices are used to close atrial septal defects (ASDs), an abnormal hole in the wall of the upper chambers of the heart that are present at birth. This market snapshot is intended to provide a high-level overview of the global ASD occlusion devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, atHeart Medical, Cardia, Hanyu Medical, Lifetech Scientific, Occlutech, W.L. Gore.

Global Markets for Aortic Grafts, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for aortic stent grafts for the treatment of aortic aneurysm. The market for aortic stent grafts includes open (surgical) and endovascular (transcatheter) aortic stent grafts used in the repair of abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). This market snapshot is intended to provide a high-level overview of the global market for aortic stent grafts, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Cook Medical, Endoron, Endospan, Lombard Medical, Medtronic, MicroPort Scientific, Taurus Vascular, Terumo, TripleMed, W.L. Gore.

Global Markets for Interventional Cardiology Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for interventional cardiology devices for the treatment of cardiovascular diseases such as heart failure or severe atherosclerosis. The market for interventional cardiology devices includes devices used to diagnose and treat diseases related to the coronary arteries. Devices included within the scope of this report include coronary stents, catheters, angioplasty balloons, guidewires, and intravascular ultrasound catheters. This market snapshot is intended to provide a high-level overview of the global market for interventional cardiology devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bifurcation Systems, B. Braun, BD, Boston Scientific, Cardinal Health, Cook Medical, Corflow Therapeutics, Fastwave Medical, Lemaitre Vascular, Medtronic, Merit Medical, MicroPort Scientific, NirvaMed, Philips, Teleflex, Terumo, Translumina.

Global Markets for Oncology Embolization, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization, and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death. This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: ABK Biomedical, Arsenal Medical, Boston Scientific, Cook, Cordis/Cardinal Health, Instylla, Medtronic, Merit Medical, Ned Medical, Obsidio, SirTex Medical, Stryker, Terumo, Varian.

Global Markets for Vascular Access Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vascular access devices, which are essential for continuous and long-term access to the bloodstream for administering intravenous drugs and fluids. The market encompasses various types of devices, including peripherally inserted central catheters (PICC), midline catheters, central venous catheters (CVC), and implantable ports. The snapshot aims to provide a comprehensive overview of the global market for vascular access devices, offering key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Access Vascular, AngioDynamics, B. Braun, Baxter, Becton, Dickinson & Company (BD), Bluegrass Vascular, C.R. Bard, Cook Medical, ICU Medical, Medline, Smiths Medical, Teleflex, Terumo, Vygon, and Yushin Medical.

Global Markets for Rotator Cuff Repair Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for rotator cuff repair suture anchors for the treatment of rotator cuff injuries. The market for rotator cuff repair suture anchors includes anchors composed of biocompatible polymers and metals. This market snapshot is intended to provide a high-level overview of the global market for rotator cuff repair suture anchors, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Aevumed, Arthrex, Atreon Orthopedics, ConMed, DePuy Synthes, Embody, Inovedis, Smith & Nephew, Stryker, Tetrous, Wright Medical, Zimmer Biomet.

Global Markets for Electrical Stimulation Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Wearable Monitoring Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Low Complexity Medical Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Canada Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Canada Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Canada. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Germany Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Germany Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Germany. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

France Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The France Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for France. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

U.K. Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United Kingdom Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United Kingdom. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Italy Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Italy Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Italy. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Spain Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spain Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Spain. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Poland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Poland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Poland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Netherlands Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Netherlands Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Netherlands. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Belgium Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Belgium Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Belgium. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Sweden Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Sweden Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Sweden. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Switzerland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Switzerland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Switzerland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Denmark Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Denmark Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Denmark. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Finland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Finland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Finland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Norway Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Norway Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Norway. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

China Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The China Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for China. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

India Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The India Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for India. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Japan Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Japan Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Japan. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Korea Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Korea Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Korea. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Australia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Australia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Australia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Thailand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Thailand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Thailand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Malaysia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Malaysia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Malaysia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Singapore Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Singapore Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Singapore. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

New Zealand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The New Zealand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for New Zealand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Caribbean Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Caribbean Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Caribbean region. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Argentina Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Argentina Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Argentina. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Colombia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Colombia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Colombia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Chile Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Chile Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Chile. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Guatemala Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Guatemala Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Guatemala. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Dominican Republic Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Dominican Republic Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Dominican Republic. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Costa Rica Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Costa Rica Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Costa Rica. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Panama Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Panama Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Panama. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Mexico Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Mexico Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Mexico. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Brazil Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Brazil Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Brazil. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Turkey Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Turkey Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Turkey. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Russia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Russia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Russia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Africa Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Africa Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Africa. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.
Schedule Meeting
Request Info
close
Video Transcription
close

Nick Pachuda  0:05  
Welcome everybody. I'm Nick Pachuda, partner at Neve capital and Precision Life Science Partners, and we're excited to be able to put this panel on. It's like we want to make it as practical and useful as possible. We put some incredible people on the podium with very diverse backgrounds, and that's how I like to do these panels, to be able to share practical information from people that are living it every day. So with that, let's let our panelists get introduced. So let's just go down the line. Jeff, please.


Jeff O'Donnell Sr.  0:34  
Jeff O'Donnell, Sr, I am at Runway Healthcare. Runway Healthcare is a venture studio, and my background is in cardiology and orthopedics with J and J Boston Scientific and then on my own for a long time,


Tamir Meiri  0:49  
I'm Tamir. I'm part of jddc, J and J's corporate venture arm. I'm based in the Bay Area, originally from Israel, if you haven't figured it out by socks at this point, I've been with JJ for 12 years, and I lead our Medtech investments on the West Coast.


Rui Jing Jiang  1:05  
Hi everyone. My name is Ray Cheng Jiang. I am founder and CEO of Avisi Technologies. We are developing nanotechnology based implants to treat glaucoma, headquartered in Redwood City. We also have a presence in Philadelphia, and it's great to be here with you. 


Stefan Fischer  1:18  
All right. Good afternoon. Steffen Fischer from TVM Capital, based in Munich. We are a pure life science investor with the company for almost 25 years now, managing partner CFO, and happy to be here, looking forward,


Nick Pachuda  1:33  
Awesome. So everybody on the panel is on a board or built a board. Had, you know, good experiences, challenging experience is we've got, you know, corporate board members, institutional investors, CEOs and those that have done all of the above, right? So with that, we're gonna go through some basics, and then we'll work our way into maybe some of the harder topics. So the first thing is just simply to the board, to the panel. Sorry, you know what purpose does actually having a board of directors? What is the purpose of a board of directors? What should they be actually doing? Just anyone, please.


Jeff O'Donnell Sr.  2:08  
I think the Board of Directors, to me, has a different skill set, and the CEO has a different need at different stages of the company. So at the early stage of a company, you might be looking for a board of directors that can help you access maybe a design team, or board of directors that can help you with capital, navigate through the FDA, those types of things. And then the commercialization phase, you might have a different need. You might have a need for somebody who's been there and done that and rolled out products with either distributors or direct employees, and then the public stage again, a different set of needs. So I think you know that it changes as the company evolves and and I think maybe you have to change board members gently in and out as your needs change. 


Nick Pachuda  3:03  
Anybody else want to chime in on that one? 


Tamir Meiri  3:03  
So, I the way I like to see it is there's the official part of the board, the fiduciary duties, the legal responsibilities, but then there's the unofficial part, where it's really sometimes being a friend or a shoulder to cry on, but realistically also somebody to blame at the end of the day, and not realistically And seriously, in the sense that some decisions a CEO doesn't want to agree with, but he could say, well, the board doesn't agree with it, right? So it's not just your own responsibility as CEO. And I think other people who are CEOs in this room originally, you probably know this, right? A CEO is a very lonely job, despite having some co founders, right? So having a sounding board or somebody else to talk to and work through some of your problems and questions is really important.


Rui Jing Jiang  3:43  
There are probably some entrepreneurs in the room with us today, and maybe you don't require any sort of outside financing. We kind of were at that point. At the very beginning, we were fortunate to have grants and we didn't need to have a board, but we found a lot of value in bringing on an independent board member. Early on, we brought on Gary Pruden, who's the former worldwide chairman of medical devices at Johnson and Johnson, and for us, first time founders, he was able to help us see around corners and actually help us attract that first tranche of financing. So I think there's also a point, even before you attract investment, where a board member can be very useful.


Stefan Fischer  4:17  
No, absolutely. I agree with you what has been said so far. I think the board itself, it's, in our view, is it's kind of a sounding board, it's Coach, it's a partner. It's not really an opponent, I mean, on the one hand side, clearly challenging the CEO or the management team on the one hand side, but in a good spirit, in a constructive fashion, and and with doing so, I think it's pretty important that you have a diverse board, right, with different angles. And as you said, I mean, that evolves over the period of time. I mean, at the seed stage is definitely something else, when once you are commercial and in between. So I think the the magic really lies in bringing the right people at the right time,


Nick Pachuda  4:55  
right? I mean, you know, we're hearing about, you know, you have board. Members that are investors. They're there for a reason. There are those that can help you with talent, right? They can help you find other great team members. There's those that are going to be great at helping you with fundraising, depending on the stage that you're at, some can help you with operational expertise. What do you need to do to actually run that company? And then there are those that may be able to help you with business development, partnering exit strategy, or finding an investment bank, or whatever you might need, and it's depending on that stage of the company. So I agree, having a diverse board that is time specific, stage specific for you is really important, and those boards are going to evolve over time. So let's take a one step deeper on complexity. Now. I'm gonna go to Tamir. There's get questions all the time about corporate board members as a corporate venture lead, when you sit on a board, what are the advantages, but what are some of the complexities and how the CEOs have to manage that situation?


Tamir Meiri  5:52  
Yeah, so for folks who don't know, jgc, we are actually the first corporate venture effort. So this is our 52nd, or third anniversary. At this point, I'm blanking on the air. So we've done this a long time, and over the years, we really realized how to best structure JDC within the organization, but also externally. So the way we operate is, after we've made that investment in the company, we're completely firewall from the business in that respective area, so there's no information flow going from us being board members in a company into the operating company and vice versa. So any direct relationship between the company and the operating company and j and j has to be done directly, ideally not including us. If they ask for it, we're happy to be included, but to manage any potential conflict of interest. So for us, and I can't speak for other corporate VCs, but the best way, or the best practice, has been we are fiduciaries of the company, and we're not fiduciaries of J and J being boards of the company, even though we are J J plates. So that's how we view it. Essentially,


Nick Pachuda  6:46  
did, do you find that your CEOs find value or complications of having a strategic on the board.


Tamir Meiri  6:54  
So very case dependent, right? The answer, very CEO dependent. I won't name names, right? But I will just give two examples from the same domain, right? None of these were disclosed investments, so it makes my life easier. But in one investment, it's in the neurospace, early stage companies, we were very much involved. They get a lot of value from our operating company. They provide a lot of guidance on clinical trial design, on manufacturers, on providers that first will be good for them, but in the case of an onboarding into J and J down the road, 345, years, these are providers and service providers we work with. So it will make an onboarding and simpler procedures, rather than switching it in the middle of an acquisition on the other company, which is a much more advanced company and much more, say, experienced entrepreneur who's had three or four exits to every other strategic you can think of there has been, I guess paranoia is the right terminology, or suspicion, even though we've explained everything and everything had to be set up in legal agreements, or it's significantly complicated more than they should have been, just to make sure that the firewall is written, pen to paper, even though everybody who's worked with us know that that's how we operate. So it varies. I think if you lean in and you understand the amount of value a corporate can give you, I think it's only going to be beneficial to the company. 


Stefan Fischer  8:03  
But there might be situations coming back to your complexity. There might be situations when you have a corporate on the board that you discuss topics, where it might be from a corporate governance perspective, advisable that you recuse yourself, go, go outside the room, and then you can discuss it in more open. Yeah,


Tamir Meiri  8:27  
that that, I think we've all been there, right? So if you're not specifically asked to recuse yourself, I think it's kind of your own responsibility to know when to recuse yourself, right?


Nick Pachuda  8:37  
Yeah, but that's an important topic, you know, because we get that question all the time. You know, what happens when there's a corporate on the board and they're not gonna be on the board if they don't know how to manage that situation and avoid conflict of interest, when there's even potential, you're gonna recuse yourselves, particularly around M and A conversations, and you know, but everybody knows that going in. So I would say, for those you know, first time CEOs that haven't been down that road before, it's manageable, and it happens all the time, so I've been this part of this panel is just to get you more comfortable with that. Maybe that's a good question. How many CEOs do we have in the audience? And I assume most you have board of directors. How many of those boards are perfect? Yeah, yours right, of course. Yeah. Perfect. Awesome, perfect, yeah. So maybe it's practical that we're doing this. So let's let this is my favorite question of this session, what a good boards look like? You know, functional boards. And what are we get? Some examples of them where there might be some challenges but ruin what does a What does a good board look like? I think yours is particularly interesting and does quite well. What does that board look like? 


Rui Jing Jiang  9:39  
A couple different things. I think everyone brings a unique perspective and experience to the board. We've got somebody with many decades of large corporate experience who can see strategically the big picture and the long horizons and the potential challenges that we may face. We've got somebody who's grown up in a very successful organization. Dr Catherine Moore with intuitive starting in engineering all the way now to running the foundation, having that operational experience. And we've got Paul Norris of bacanto partners. He's a lawyer, but he's been through many, many transactions, even as an operator CFO of a publicly traded company. So I think those are some examples. Nik, you've been to a couple of my board meetings, and when you chime in about certain things, you know, we're all ears. So I think at the end of the day, the folks you have on the call, if they're able to speak to the particular agenda of that meeting, you find yourself getting through the topics very efficiently, and there's not a lot of time wasted on getting to the meat of what you're discussing, what you should be doing, and thinking about this company. So I think I have a pretty good board. And yeah, looking forward to keeping it that way. 


Nick Pachuda  10:48  
Anyway, examples of good operating boards and what that looks like. 


Stefan Fischer  10:53  
It looks like. It's an engaged board. I mean really asking questions, really asking the right questions, challenging you, as I said earlier, but also communicating among themselves. So it is the horror, or the nightmare you have on the board is, it's a rubber stamp board, right? Silent, just nodding to everything, what the management is coming up with. And then I think there is no value in but really in an engaged board that that's crucial for the success of the company. 


Jeff O'Donnell Sr.  11:21  
I think that's, I think that's right. I think that one of the biggest mistakes young CEOs make, or young companies make, is they're dying to get a superstar on the board. They're dying to get that ex CEO of Medtronic, brand name, the brand name, you know, they run around these meetings and they say, you know, this person's on my board. Well, that's great. That's great. But I think the work before we put a board together, you have to have the guts to really interview board members and not just take people that want to be on your board, and never beg somebody to be on your board. You want people that will respond when you call them. You want somebody that's going to be open when you have a problem, because you're going to have problems and you can't have a board that you're afraid of. I'll end with this. I had a board one time that he that started out everybody's interest were aligned. The goal of the company was to build the product to soft, you know, do a soft launch into the market to prove that the dogs are going to eat the dog food, and then to exit. As the board evolved and other investors came in, some investors would put somebody on the board and the CEO at the time me did not really fully educate that board member on what the goal of the company is, and so that board member's interest were not aligned. It can also happen when you have investors that are giving you money out of different funds. You know, one fund, you might say, I just raised $600 million I've got eight to 10 years to get my money back. I'm ready to go. You might be talking to a VC that said, Yeah, I'll get in on this round, thinking that you're going to sell the company in two or three years. Next thing you know, the board says, now we're gonna go long and that can just be a torture, you know, torture for the CEO. So I think it's, you know, in the beginning, either get an executive chairman or somebody that's been there and done that to help you interview board members.


Nick Pachuda  13:38  
So maybe that's, yeah, no, I was gonna say you just mentioned executive chairman versus Chairman versus board member. There might be folks in the audience that maybe are unclear about we know what board directors mean, but what's the responsibility of a chairman? And then we're gonna go to what's the responsibility of an executive chair. So you brought it up, Jeff, so go ahead and board of a chairman.


Jeff O'Donnell Sr.  14:01  
Yeah. I mean, I'm on six words now. I'm chairman of two. I I think a chairman, you know, keeps the team together, right? That's the coach. Keeps the team together. Make sure that your parliamentary processors are being accomplished and, you know, helping the CEO and the rest of the board members understand the strategy. I'm an executive board chairman of a company in Pittsburgh, and the the entrepreneurs are like, 35 years old, right out of Carnegie Mellon, super, super smart, first job they ever had. And so I'm the old man in the room, but I'm able to call on people, because I've been around for 40 years in the industry, and help these entrepreneurs and help the CEO get to the next level. The executive chairman, to me, is really the CEO's boss, but, but help her. So you're going to lean. In a lot you're going to be you're going to be taking phone calls three, four times a week. You're going to be going to these meetings with that CEO. You're going to get him to the next level, or get her to the next level. I think that's the difference. It's a lot of work to be an executive chairman.


Rui Jing Jiang  15:17  
That point you brought up about joining the CEO on meetings, you know, I think that's so important. I've heard from other folks. You know, I wish my board member knew as much about my company as your board member knows about your company. I think it is your responsibility as CEO to make sure your board is educated on what you're doing, such that they can be an asset to you. Right? There have been countless calls like diligence calls where a board member you know needs to be there because the investor has requested, and if you're waiting to prepare your board member then or your board member isn't up to speed, it's too late.


Nick Pachuda  15:50  
Yeah, right. I'm gonna double down on that for a minute, education versus collaboration. And particularly, you gotta make decisions at the board level. If you're spending too much time in a board meeting, educating, right? Tons of slides, lots of information, because the board member hasn't seen it before, and now you're asking for a decision. I think doing that leg work in advance, socializing with your board members. I never like surprises in a board meeting, right? That's a bad way to for decisions to be made. So the idea if you can educate and socialize in advance, so that you're able to collaborate, engage, collaborate, and decide when necessary or challenge appropriately, when you find, if you find yourself doing a lot of educating during your board meeting, you've skipped a step before the board meeting.


Stefan Fischer  16:37  
But Nick It's all about communication, right, right? I mean, we I was on a board where the CEO was very reluctant to communicate in between. So the first four or five, sometimes six hours of a board meeting were updating what happened since the last board meeting, which was annoying, and then when it really turned down to the decision making, everyone was so tired. So when I took over the the chairmanships, and I say, Hey guys, this is not possible three hours max. And in between, we need, on a monthly basis, a CEO letter updating us on the progress so that we can have a solid and educated discussion within the next board meeting, not this update, which is is a time consuming exercise.


Tamir Meiri  17:15  
I think a lot of the housekeeping goes about setting expectations at the end of the day, right? You need to understand why your board members are expecting of the CEO. Expecting of the CEO and vice versa, right? We just closed an investment before the end of the year, first time entrepreneurs, very bright entrepreneurs, but it was clear that the board was comprised of friends and family and their legal counsel, who's great as legal counsel, but not really the best board member. And we built a board by telling each board member what it is expected of him to be right. One was more on the entrepreneurial side, has gotten to an exit recently. The other one has done five exits in this space. He's knows the manufacturers, all the strategics and everything. So it's really about setting expectations, what's expected from each board member. And the same goes back to the CEO potential. 


Nick Pachuda  18:00  
Well, let's talk about communication for a minute. The both at a board but prior to the board meeting, because that's you're right, it sets it up for success for that meeting. What do you like to see in advance of a board meeting, with regard to prep, both personally and maybe in writing or PowerPoint or whatever, Regina. What do you like to I know you do it quite well. How do you prep for a board meeting? And then we'll see what other folks like to see.


Rui Jing Jiang  18:20  
I like to just get on the phone. Honestly. I'll call each board member up. I'll give a quick little update. Hey, this is what we're doing, by the way, when we're gearing up for our next board meeting. These are some of the topics I like to talk about. These are some of my current challenges, and I think having those little discussions beforehand helps shape the materials as well. I try to send it out in advance, give people a little bit of time to just look through, and then I try to bring functional leads to the appropriate meeting as well, because I find that sometimes our board members want to hear it directly from those folks, right? Can add a little bit more color and dynamics to what I've already prepared people to think about so I would say my approach is just to be fairly transparent, fairly communicative on an ongoing basis. 


Stefan Fischer  19:10  
The thing you bring up good point, bringing in your of your department heads or leads, as you just said, I think it's on the one hand side is also appreciating their work and giving them some air time with the board, because otherwise this board is somehow a strange beast or whatever, right if you haven't been part of it, so I think that's the right thing to do. And on the other side, giving the board members the opportunity to ask very specific topic related questions and get the answers firsthand.


Jeff O'Donnell Sr.  19:38  
I think the communication is the key to so many different relationships. But you you really need to communicate at least quarterly with your investors, and you really need to communicate with the board members. There's certain board members. I'm one of them who would if I walk into a board meeting and we were going to spend at the end of the board meeting when you're kind of tired. Now we're going to go through the finances, line by line. That's like, silly, right? So what you want to do is, you just want the CFO to say, I sent the finances out two weeks ago. I'm sure you had a chance to read it. I talked to a few of you prior to the board meeting. Can I get them approved? That's about, you know, that's communicating with your with your investors and with your board. I also you mentioned one thing I really think the board meeting is, you know, 90% management. I like to show off the management of the company, assuming there is management, right. But once the you know, once you can get the you know, the marketing person up, the manufacturing person up. Even if the manufacturing person is a 1099, or an OEM manufacturer, bring them in for the board meeting and showcase your team. Show everybody what your infrastructure looks like. Then it's not all you, yeah, yeah.


Nick Pachuda  20:58  
That's a great comment. You know what I what I like to see in advance is keeping it simple, right? I like a phone call raising, you know that phone call of, hey, this is what we're doing at the board meeting. You need to know X, Y and Z, we're making this decision, right? That is so helpful. And then, you know, there's always an agenda, okay? What's actually on the agenda for the meeting? And if I see more than four or five bullets, I'm like, hold on a second, right? We're not gonna have that much time. And then a pre read, and I've seen companies absolutely shut down operations to prepare slide decks for board meetings every quarter that that is a terrible use of resources in time. And if your practice is you feel like you need 50 or 60 slides to take, you know, your board through the whatever needs to get done. That's a mistake, right? Unless it's an incredibly important set of M A you have 10 term sheets and you everything's going bananas in your company. But normally it's very efficient. Let me just ask that in a pre read, how many, how many slides Do you like to see in a board deck pre read? Just give me a number guy,


Tamir Meiri  21:57  
10 and 15. Yeah. 


Stefan Fischer  21:59  
Something like that, 20, max.


Nick Pachuda  22:03  
It's the same thing if you have to present on this podium this week, and you've got whatever eight minutes, you know, you can only do one slide a minute and make it happen, right? You know, more communication means you missed doing something in advance, right? And then maybe we'll shift to during a board meeting. You know, what, what does it look like when it's an efficient, successful board meeting? And where do you see sometimes things get derailed? I know we talked about a little bit, but I want to talk just operating a board meeting, aside from, you know, the minutes and getting things moving and making the fundamental decisions that have to made in any meeting, what, what does efficiency look like? And then let's talk a little bit, though, about where we've seen, you know some conflict or challenges in a board meeting. So what's success look like? But what does challenge look like as well? 


Jeff O'Donnell Sr.  22:46  
To me, success in a board meeting is when your board members and managements, again, their interests are aligned, but your strategy conversation has already happened before the board meeting, so everybody understands the strategy. You don't have to have a brainstorming session in the board meeting. That's just not the mind for that. And I think the other you know thing that can make a board meeting efficient is to when it comes to strategy, is to have that be a separate meeting, something totally and we're gonna ad hoc, we're gonna get together for a weekend, or we're gonna do something and we're gonna talk about, you know, the term sheet that we got, or the distribution agreement that we got, or the FDA problem that we have, and really kind of try to compartmentalize those big, big issues. Yeah,


Tamir Meiri  23:42  
I'll add that, you know, again, PrEP is really, really important to make it successful. And you know, some of my companies do a prep call a week before to ensure that, first of all, you've reviewed the slides if you have any questions, and then target the conversation at the board to the really important topics, so you're not reviewing slides on the board. You're discussing the slides on the board right, similar to an investment committee to start next,


Stefan Fischer  24:05  
that's that's important that not only sending as a pre read the slides, but also assume that everyone has read them. I think this is again requisite for for for a constructive discussion, but talking about efficiency. I mean, my colleague now said that I'm as a finance guy like structured things. So my recommendation would be a clear agenda with time allocation to that so you can keep track. Secondly, is also within each bucket or chapter you want to discuss, is really, what is the expectation? What are the the resolutions you want to take so that you can really, during the board meeting, say we are on track, because sometimes you tend to spend an hour or two on topic one, and then you're missing out on the rest, right? So it's really that, and that's then the the role of the chairman saying, Okay, we to guiding the discussion a little bit and keep everyone on track.


Nick Pachuda  24:55  
Let's talk a little bit about decision making every board, almost every board. Mean, there has to be some sort of a decision made. And I think, Jeff, you brought up a good topic, is that brainstorming sort of is not a great thing to do at a board meeting where you're tight on time, you have a specific agenda, you want to knock through things efficiently. So I like to recommend a framework for decision making in boards, right if you're going to come and a decision has to be made. Number one, what is the decision that has to be made? And does everyone know that's coming in advance, right? Number two, are you going to present options? Do you have pros and cons of those options? And then a recommendation, right? And I want to see a recommendation with timeline, resource, cost, you know, valuation impact, if necessary, financials to go with that, and then what action has to come after that? It is the mistake I see. Are folks that come and say, Hey, let's just talk about this topic. We got a term sheet. What do you think? Right? As opposed to, I've got a term sheet. I have option A, B and C. Here are the ramifications of those, and here's what I recommend, because you're the CEO of the company you have to lead. Can you make a recommendation? And do you understand the strategic, financial, clinical, you know, valuation impacts of what you're recommending? And have you thought it through again, but it's back to that comment of, let's not figure it out on the fly during a board meeting.


Jeff O'Donnell Sr.  26:16  
Yeah. I mean, I think that it's a good practice in my experience, just a good practice to have the board members come in the night before, maybe have a meal together and talk about some of the things. Make sure that the slides were reviewed, ask them their opinion on maybe the problem, whatever that problem is, the regulatory problem. Have you reviewed the term sheet that we got last week? You might get no's. But then, you know, maybe that evening they can come to the board meeting a little bit more prepared. The Board member that I really have a problem with is the board member that comes in 15 minutes late for the board meeting because the flight was and the cab was and all that stuff, and then I have a flight back at three, so I'm going to have to leave at two, and they're out of here, and they came unprepared. That's the role of a of a chairman, to make sure that that board member, either, you know, has different expectations when they come in, or is kind of removed then and moved out. The second part of your your your question, I think, is, how prepared is the management team for the board? Do you? Do you hold the management team to quarterly SMART goals? Or what are the corporate goals? Going over the corporate goals at every single board meeting and having the management team talk about, you know, the corporate goal is to file the 510, K in April. And as head of engineering, I'm going through the quality systems and everything, and I'm helping us hit that goal. And I'll end with one thing, if you have a real problem, like a regulatory problem or some type of a legal problem, don't, as a CEO, don't, don't take on all of that responsibility. Bring in your regulatory advisors, bring in the lawyers, bring in the accountants. And when you, as you said, you know your recommendation is or your options are one two, and this is the management recommendation. Understand the financial impacts of that and make your recommendation, but do it with experts behind you, yeah.


Nick Pachuda  28:29  
So let's talk about maybe the topic of fundraising for a minute, because it comes up. And you know, obviously, if you can, if a CEO can tap into their board to help with fundraising. Warm introductions, et cetera. But let's talk about it, because I see it sometimes tip too far in a direction where a CEO is expecting the board to sort of lead the capital raise process. Have you guys seen that? I've certainly seen it. What's I think when it comes to capital raising. How do you see the role of the CEO versus the role of the board? Anyone? 


Stefan Fischer  29:05  
Well, when they didn't, I would even spend a little bit wider it's not only the responsibility of the CEO to answer your question. It's the responsibility of the board. Because, I mean, the board is not micro managing the company, right? But now bring in another aspect, I would say, for an efficient and successful fundraising, you would also be very well served to have a CFO driving the process and preparing everything. Not only that, I'm the CFO, as you know, but that's my experience. Because again, bringing in other people, delegating things, so you can team up, and once in a while it might become important, because the investor wants to see the board that the chairman is joining, but it's not. He's not the showman. He's not the driver of the entire process.


Rui Jing Jiang  29:50  
In my experience, the board is definitely complimentary most investors. I mean, you all are investors, right? Want to hear from the CEO and understand who they are. Investing, right? We often hear the team is the most important asset at the company, especially in the early stages. So I definitely view the board as more complimentary coming in to say, Hey, these are your potential future colleagues, if you invest enough to have a board seat. But that's really it. 


Tamir Meiri  30:14  
Yeah, I think it's a combined role, right? To certain extent, the CEO should rely on the board and vice versa. You know, the earlier the company, the less experienced the CEO. Obviously, the board is going to have a much more significant role. What I hate to see, in a lot of cases, and it's kind of an early stage company problem most of the time, is that he's the CEO. Would ask for a lot of introductions, which, you know, all of us do have, because we're in that network, and he just doesn't follow up on her. That's like, the most annoying thing ever, right? Because you're putting your name on you're like, hey, this is a company I'm invested on. When did you come in take a look at like, Oh, I forgot to follow up on. That's your old


Jeff O'Donnell Sr.  30:49  
Yeah, I think, I think the board could really help the CEO prepare for those meetings. You know, going in and saying, you know, why are you calling on NEA? NEA hasn't made a investment in dermatology in the last 10 years. So that's where the board members can really help, you know, pointing them in the right direction, but not necessarily doing the job for them.


Stefan Fischer  31:11  
Well, actually, I mean, as I said, I've been talking about the the roles of the board members from as an investor, before you send out the CEO for fundraising, you clearly challenge him and say, This is what I would like to see. I mean, clearly we are always asking also to to re up our investment. But nevertheless, I mean, there you can give guide and say, this is investor X or Y, Z want to see, right? This is a story if you want to sell it, because otherwise you will not be successful in your fundraising assets.


Jeff O'Donnell Sr.  31:37  
I'll add one thing, if you don't mind, a lot of the CEOs in the room, you're probably saying, you know, yeah, I mean, yeah, I can bring the CFO with me. I don't have a CFO, or I can't afford a CFO. But in today's world, things have changed, and fractional CFOs are very, very accessible, and we don't mind them. We just love their expertise. They have relationships with audit firms. If you don't get an audit, you get an accounting review. You know, you can't do everything yourself, and if you don't think you can afford it, the fractional side, the companies like yours, by the way, you know Can, can provide fractional marketing people, fractional CFOs.


Nick Pachuda  32:21  
So let's as we talk about adding resources sometimes to the board there's certainly, you know, say you're doing a series a and there's going to be multiple VCs that are coming in on that, and that are going to expect board seats or observer positions. But let's talk about the role of an independent board member. When does that make sense? And what do you look for in an independent board member, anyone


Stefan Fischer  32:43  
Right from the beginning. Right from the beginning, as I said, we are repeating ourselves. I mean, it needs to be diverse board, given where the company is at West stage. But clearly there is a trend that several VCs will send their nominees to the board, and then you have a heavy, loaded VC board, which can be healthy, but most likely it's not adding additional benefit, or that benefit you are looking for as a CEO. So therefore, if there is a in, an educated VC, I would say bringing in, then at the right time, an independent, I mean, clearly we have nomination right, and then we can say, well, maybe I go on that, but perhaps, and we just had that, for example, in one of our portfolio companies where say, well, we bring in an expert because we think that is bringing more value to our investment. I mean, I can always be an observer, right? So I don't need to worry about that.


Nick Pachuda  33:35  
Yeah, raging. How did you think about it when you got to bring in independents? When do you look at the needs of the company and sort of match it up, as opposed to maybe letting your board members fill those spots or make recommendations for you? How do you manage that? 


Rui Jing Jiang  33:51  
As I mentioned, we brought on our independent Board Member fairly early on because we needed some help thinking through aspects that we just didn't necessarily know how to tackle as first time founders. And there were things that our independent was able to bring to the table. You know, with their network and with their for example, brought brought along a great biocompatibility expert in our case, who was able to help us with some initial studies that then attract turned into grant financing. Attracted funding helped us think about how to build a quality management system, I mean certain things, and then getting us access to those resources in the early stages was very critical now, as we've gone on to raise seed and now, you know, raising our Series A and having a first close on that thinking more strategically about okay, what are the specific committees we need to have, whether it be compensation or audit or other things, what role does that independent play? Because they have a different incentive than Vc investors, right? And so it provides more balance, I would say to the board, from my perspective,


Nick Pachuda  34:53  
you know, sometimes I'll get asked about, hey, I've got a I've had a challenging board, or I've got a couple of board members. I'm not sure it's. Is, you know, working the way I would expect. One of the things I encourage CEOs to do is, you know, once a year, assess, assess the board. You know, if you know, given the stage that's specific, where are you within company, and what are your top three or four needs for that year or that phase that you're in, and then look at the board and say, Look, are we in talent recruitment phase. Are we fundraising? Are we, you know, operating and cranking up to a commercial launch? Are we at m and a stage or IPO stage, and based on your board members, of those board members that, especially those you have optionality with some you don't, right? But how are they? How do they do on those key categories, based on what you need for your company at the time, and then do a gap analysis, and where do you need to add? And then look at the profile the people that you want to add and fill that gap. If you need a commercial you can get Chief Commercial Officer, you can't find one, but you can get someone on your board that can get you access to a number of people that can solve that problem. But that comes from assessing what's going well, what's maybe challenging, and doing that on a regular basis, and I think that's sometimes okay to communicate to your board or the board chair is, hey, look, I've got a gap here. What do you think we've got to maybe fix this? Maybe it's on the leadership team, but maybe it's at the board level.


Rui Jing Jiang  36:12  
To that point, Nikki, you just reminded me, sometimes investors play a big role in actually giving up their board seat to that functional expert, 


Tamir Meiri  36:22  
or bring them in server or another audience,


Rui Jing Jiang  36:25  
yes, or a guest, or something like that. So communicating with your investor board seat. I mean, sometimes that there's flexibility there, yeah, okay,


Nick Pachuda  36:34  
well, let's talk about going in the other direction for a minute, how the boards can affect the CEO, right? Because, you know, I think there was a panel this week that founder doesn't always equal CEO, right? Or the phrase that, do you want to be a successful entrepreneur, or do you want to be a CEO, right? And think about that for a second. But you know, with that in mind, sometimes that role of the CEO has to evolve, or the chair they're sitting in needs to evolve. How do you manage that as a board when you've got to evolve the role or the chair that that that that that CEO is in?


Tamir Meiri  37:10  
So I'm going through that with one company, but I've gone through that before, some with unfortunate circumstances, with a CEO, and some with, you know, quite expected circumstances CEO. So I think again, we said it all throughout this, this discussion right setting expectations is probably the most important thing. You need to tell the CEO from the initial inve if an investor, from the initial investment you are expecting to bring in a more commercial stage, CEO, when commercialization is part of that, when you're potentially looking at an IPO, not every successful private company CEO is a successful public company. CEO, everybody looks at Zuckerberg and says, Oh, he's been the founder. He's been there all along. Then that's the unicorn, right? And you don't see a lot of those. So I think a lot of it is about setting expectations and understanding what's expected of the CEO to achieve. And in some cases, and most people are grown ups and adults and can say, you know, mea culpa, or I just can't do this. I don't have the capabilities. I'll step aside, or I'll step away. Not always it is a pleasant conversation, but you know, we're all adults,


Stefan Fischer  38:07  
but what is sometimes very helpful. Coming back to your point about assessment, you can also bring in an HR, C level assessor say, Okay, what do we need in terms of the next steps in the company? And is our management or the CEO capable of that, because then you have an other discussion based on a third party opinion, rather than just doing bug for yourself,


Jeff O'Donnell Sr.  38:28  
yeah, yeah. I think it's a it's always different, right? Because if you have a CEO that's been a CEO, you know, three or four times, and their their process is, they go to mgh, or University of Pennsylvania, and they license technology, and they put their team in place that's a different CEO than the engineer that came up with an idea and has never been the CEO before, right? So, you know, it's it just to me, feels different again, I think it goes back to the first question, being open with the CEO, communicating what reality is going to be with the CEO and the board members. And one thing I didn't say earlier that I I like to say now, is when you're going to bring a board member in to your company chat and observe for couple meetings first to see if it's really what they want to do and and then to understand how many phone calls we're gonna we're gonna, you know, have in a month, and make sure that they're gonna lean in, lean in, real hard to help you. 


Stefan Fischer  39:36  
Well, it's a fundamental question. When you reach out to an independent board member. I mean, we just did it. The first question was, clearly, do we have interest? But the second was, do we have capacity? Right? All right, yeah.


Nick Pachuda  39:47  
So we got about a minute left. I like to do this on my panels about parting shots. So what is one thing that we can tell as bunch of CEOs in the audience, what maybe something that you think is the most important to help them as they're thinking? About, you know, building a board or evolving a board. What's the one piece of advice you want to give everybody?


Jeff O'Donnell Sr.  40:06  
I think I think hard about being President, CEO and chairman of a company. I think in the beginning, you might want to separate that,


Tamir Meiri  40:15  
I agree with that. I'll say the board is not your enemy. So a lot of people treat it that way. Use their expertise, your knowledge, use their network. Treat them with respect, obviously, but use them. They're there for you really


Rui Jing Jiang  40:31  
totally agree. I would say the board is an extension of your team. So the same way you think of hiring the right talent, think of how you get that right board member, and the same way you rely on your team, rely on your board members and bring them in .


Stefan Fischer  40:44  
Absolutely just the board is your support and not a pain.


Nick Pachuda  40:50  
Yeah, I would leave with ru Jing said the communication you can take a board and take your skills and be a resource multiplier. You can be exponentially more valuable with a great board and it can add tremendous value to your company. So in my opinion, learn, engage, communicate, and multiply your resources by having great board members and managing them well. So with that, I thank everybody for your time. Anybody has any questions, meet us after Thank you. 


Tamir Meiri  41:18  
Thank you.